{"id":"W2096365365","doi":"10.1007/s40261-015-0302-x","title":"Safety Profile and Costs of Related Adverse Events of Trastuzumab Emtansine for the Treatment of HER2-Positive Locally Advanced or Metastatic Breast Cancer Compared to Capecitabine Plus Lapatinib from the Perspective of the Canadian Health-Care System","year":2015,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"ca_institutions":"Roche (Canada); Santé Montérégie; Thornhill Medical (Canada)","funders":"","keywords":"Lapatinib; Medicine; Trastuzumab emtansine; Capecitabine; Trastuzumab; Adverse effect; Oncology; Internal medicine; Breast cancer; Clinical trial; Metastatic breast cancer; Taxane; Cancer; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001291123,0.0002256307,0.0005565958,0.0006912012,0.0004031397,0.001165472,0.0005005567,0.0004409897,0.00218474],"category_scores_gemma":[0.006804695,0.0001517085,0.001848483,0.001088596,0.0002851841,0.0003717631,0.0003243808,0.001003552,0.00009193189],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01198909,"about_ca_system_score_gemma":0.006392689,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.2007463,"about_ca_topic_score_gemma":0.3257331,"domain_scores_codex":[0.9985967,0.0004154732,0.0001167938,0.00009434112,0.0005345757,0.0002420651],"domain_scores_gemma":[0.99642,0.001012575,0.001331212,0.00007588854,0.0007020434,0.0004582897],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06861283,0.001077811,0.6650617,0.001367743,0.006753197,0.001496154,0.0003927201,0.02042575,0.004067893,0.003005144,0.007580639,0.2201585],"study_design_scores_gemma":[0.001641181,0.005275421,0.9733018,0.0002432728,0.003274692,0.001001261,0.0004439726,0.009231546,0.0007972036,0.0005330322,0.004185885,0.00007085906],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9730652,0.01549222,0.0002370833,0.002464653,0.0000511043,0.00008753197,0.002749824,0.000009562069,0.005842727],"genre_scores_gemma":[0.9973674,0.001425426,0.00008978382,0.000205203,0.00003277827,0.000008382897,0.0005575282,0.000002041138,0.0003114629],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9880109,"threshold_uncertainty_score":0.3991558,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08230834484887428,"score_gpt":0.4112497931627099,"score_spread":0.3289414483138356,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}